COVID-19 Vaccines and Herd Immunity

With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020. Related Article(s): COVID-19 Vaccines and Herd Immunity The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines Herd Immunity and Implications for SARS-CoV-2 Control Herd Immunity as a Coronavirus Pandemic Strategy